--RBC Raises Price Target on Onconetix to $459 From $450, Keeps Outperform Rating

MT newswire2026/10/08 11:36

By:MT newswire

07:36 AM EDT, 10/08/2026 (MT Newswires) -- RBC Raises Price Target on Onconetix to $459 From $450, Keeps Outperform Rating

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

If Hormuz Reopens, Which Moves First: Oil, Stocks, Gold, or Bitcoin?

CoinEdition•2026/11/10 08:18

Ripple Escrow Protects XRP Price. Here’s the Proof

TimesTabloid•2026/11/10 08:00

Goldman CEO Solomon Defends US Data Center Buildout After Democratic Midterm Wins

BeInCrypto•2026/11/10 04:54

Dow Jones Top Company Headlines at 11 PM ET: The Spy Scandal That Lays Bare Nvidia's Governance Vacuum | Anthropic ...

Dow Jones•2026/11/10 04:00